Strain-specific antiviral activity of iminosugars against human influenza A viruses
Author(s) -
Saira Hussain,
Joanna L. Miller,
David J. Harvey,
Yong Q. Gu,
Peter B. Rosenthal,
Nicole Zitzmann,
John W. McCauley
Publication year - 2014
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dku349
Subject(s) - iminosugar , virology , influenza a virus , strain (injury) , glucosidases , human influenza , microbiology and biotechnology , biology , chemistry , enzyme , virus , medicine , biochemistry , covid-19 , infectious disease (medical specialty) , disease , anatomy , pathology
Drugs that target host cell processes can be employed to complement drugs that specifically target viruses, and iminosugar compounds that inhibit host α-glucosidases have been reported to show antiviral activity against multiple viruses. Here the effect and mechanism of two iminosugar α-glucosidase inhibitors, N-butyl-deoxynojirimycin (NB-DNJ) and N-nonyl-deoxynojirimycin (NN-DNJ), on human influenza A viruses was examined.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom